HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...